A Multidisciplinary Outpatient Pathway

NCT ID: NCT04258176

Last Updated: 2021-08-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

270 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-08-15

Study Completion Date

2021-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients with complex chronic multiple illnesses constitute an increasing challenge and more evidence-based knowledge of effective practice is required. In Denmark and the rest of the world, improved health care, public health, and increased focus on early diagnosis have led to increases in life expectancy resulting in a growing population of older people living with multiple long-term conditions (multimorbidity). Today, every fourth Dane suffers from more than one concomitant chronic or severe disease, estimated to rise to 60% for those over 65 years.

National and international health care is organised and targeted as specialised, mono-diagnostic efforts for single diseases leading to lack of coordination and failure to integrate multidisciplinary patient trajectories. Danish research shows that general practice is challenged by insufficient collaboration between professionals involved in the treatment. Despite this, there exists limited evidence of initiatives aiming to improve care for multimorbid patients.

This study aims to:

1. identify chronic multimorbid patients and to analyse their use of two or more outpatient clinics, their general use of health care utilisations and their disease pattern and characteristics (Cross-sectional study using national registers).
2. develop an innovative organisational structure around a multidisciplinary outpatient pathway for multimorbid patients and to pilot-test it (feasibility study)
3. phase-III test a multidisciplinary outpatient pathway and to preliminarily evaluate the effects in patients and health professionals and on resource utilisations (effect study)

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Background Patients with complex chronic multiple illnesses constitute an increasing challenge and more evidence-based knowledge of effective practice is required. In Denmark and the rest of the world, improved health care, public health, and increased focus on early diagnosis have led to increases in life expectancy resulting in a growing population of older people living with multiple long-term conditions (multimorbidity). Today, every fourth Dane suffers from more than one concomitant chronic or severe disease, estimated to rise to 60% for those over 65 years. Multimorbidity is more prevalent in women, rises with declining social status and is associated with poorer quality-of-life. With an increasing proportion of multimorbid patients, the prevalence of polypharmacy will increase. A multisymptomatic and complicated disease pattern applies to both physical and mental illness, multiplicative effects can create a need for people within different specialities working together. Earlier studies show, that the most common chronic diseases are diabetes, cardiovascular disease, cancer, chronic obstructive pulmonary disease and asthma. Comorbid diseases tend to compound and interact, for example, COPD and diabetes are often seen in combination with cardiovascular disease.

Everyday-life of multimorbid patients is influenced by drug consumption, frequent visits to general practice, hospitalisations and outpatient clinics. A recent study showed that patients with three chronic conditions visit health professionals five times a month and spend 50-71 hours per month on health-related activities. However, studies on derivative effects of multimorbidity are scarce and research focus is primarily placed on mainly health services. Multimorbid patients experience and are in reality exposed to lack of coordination, lack of inter-disciplinary communication and overall poor care management. Individual resources and priorities in everyday life play a dominant role in navigating the tension between everyday life and the health care system. This is often extremely demanding for patients to navigate in.

National and international health care is organised and targeted as specialised, mono-diagnostic efforts for single diseases leading to lack of coordination and failure to integrate multidisciplinary patient trajectories. Danish research shows that general practice is challenged by insufficient collaboration between professionals involved in the treatment. Despite this, there exists limited evidence of initiatives aiming to improve care for multimorbid patients. Previous initiatives involve getting patients to take more active part in their disease, creating disease insight, involving case managers, patient-shared medical appointments, collaborative models and communication technology. Present on-going studies focusing on interventions for multimorbid patients are also few.

In conclusion, the evidence is sparse on collaborative approaches directed at multimorbid patients and on organising health care systems to accommodate this.

Objectives and hypotheses Hypothesis 1 Multimorbid patients have numerous contacts to outpatient clinics and are characterised as being older patients with common chronic diseases, a complicated disease pattern and frequent users of health care utilisations.

Objective 1: To identify chronic multimorbid patients and to analyse their use of two or more outpatient clinics, their general use of health care utilisations and their disease pattern and characteristics.

Hypothesis 2: It is feasible to convert several outpatient clinic pathways to one multidisciplinary outpatient pathway and to structure an organisation around it.

Objective 2: To develop an innovative organisational structure around a multidisciplinary outpatient pathway for multimorbid patients and to pilot-test it.

Hypothesis 3: Patients and health care professionals find it advantageous to convert outpatient visits for multimorbid patients to a multidisciplinary outpatient pathway, and the use of resources will lower.

Objective 3: To phase-III test a multidisciplinary outpatient pathway and to preliminarily evaluate the effects in patients and health professionals and on resource utilisations.

Materials and Methods

Objective 1:

In a national cross-sectional study, data on multimorbid patients is obtained using validated Danish registries, processed with remote access to Statistics Denmark.

Inclusion criteria:

* Patients who are diagnosed with more than one chronic disease
* Seen in more than one outpatient clinic (within 18 months, 12 months, 6 months, 3 months)
* ≥18 years of age.

Exposure and outcomes: Primary exposure constitutes chronic diseases occurring in multimorbid patients with classification a priori. Based on diagnoses (selected diagnoses chosen from previous studies), clinical, socio-demographic characteristics and the need for health care are investigated. We wish to demonstrate how these exposures are distributed by the number of concomitant outpatient visits within different time intervals of 18 months, 12 months, 6 months, 3 months.

Objective 2:

In a feasibility-design efforts will be devoted to setting up an innovative multidisciplinary outpatient pathway based on recommendations for complex interventions in the health system. It involves the process of going from a conceptual to an operational setup.

Procedure: A multidisciplinary outpatient pathway will be established at the University Research Clinic for Innovative Patient Pathways. Through literature review and specialist opinions, interviews, the intervention will consist of two or more disciplines collaborating in establishing a treatment plan for the patient. A process manual of the individual phases and a participatory cooperative approach will be used. A steering group will involve plastic organic groups (health care professionals, patients, general practitioners), which will contribute along with the hospital's task force team (center management, senior health care professionals, representatives of quality development) through process support.

Exposure and outcomes: In the multidisciplinary outpatient pathway, health care professionals will collaborate between medical specialties and examinations gathered for one joint encounter with the patient. An integrated discharge summary is sent to general practice. The exact structure and composition of the multidisciplinary outpatient pathway is part of the feasibility study. Interviews are conducted on patients and healthcare professionals to assess their experience with the pathway. Also a process evaluation is made.

Study 3: To phase-III test a multidisciplinary outpatient pathway and to preliminary evaluate the effects in patients and healthcare professionals and on resource utilisations.

In a prospective study with difference-in-difference analysis, a cohort of multimorbid patients seen in outpatient clinics is included based on the composition from the feasibility study.

Exposure: The newly established multidisciplinary outpatient pathway. Outcomes: In paired measurements, Patient Reported Experience Measures (PREM) are recorded in questionnaires before and after trajectories in conventional mono-disciplinary outpatient clinics are converted to trajectories in the multidisciplinary outpatient pathway. Questionnaires are compiled according to the literature of existing, validated questionnaires and supplemented by ad hoc questions when no existing questionnaire exists). Questionnaires are set up in the processing program, REDCap and sent through "e-boks" merged with doc2mail where replies are entered directly in REDCap through a link. Questionnaires will also be sent by letter.

The cohort will be followed for one year for data collection on health care utilisations (e.g. admissions, visits to outpatient clinics, redeemed prescriptions, contacts to general practice or emergency medical services, hospital activity/examinations). A control group of patients from other hospitals with trajectories in outpatient clinics are matched by gender, age, disease, comorbidity, and length of disease. Difference-in-difference comparisons are made on healthcare utilizations one year prior to the index date (first consultation with the new pathway). Data is retrieved from national registers.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Multimorbidity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention group

Patients seen in the multidisciplinary pathway

Multidisciplinary outpatient pathway

Intervention Type OTHER

Coordinators, assigned to improve the care flow, review and align the patient's appointments and tests in agreement with the patient's wishes. Outpatient consultations are arranged to take place the same day and schedules for care providers are coordinated. The patients' attendance in outpatient clinics are planned sequentially where the delivering specialty writes a summary to the subsequent specialty. Afterwards, the involved physicians and nurses attend an interdisciplinary conference, resulting in a joint treatment plan, with feedback and notice of modifications, which is delivered to the patient and general practice.

Comparison group

Multimorbid patients seen several outpatient clinics who did not undergo the trajectory

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Multidisciplinary outpatient pathway

Coordinators, assigned to improve the care flow, review and align the patient's appointments and tests in agreement with the patient's wishes. Outpatient consultations are arranged to take place the same day and schedules for care providers are coordinated. The patients' attendance in outpatient clinics are planned sequentially where the delivering specialty writes a summary to the subsequent specialty. Afterwards, the involved physicians and nurses attend an interdisciplinary conference, resulting in a joint treatment plan, with feedback and notice of modifications, which is delivered to the patient and general practice.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients seen on two or more outpatient Clinics at Silkeborg Regional Hospital
* 18 years old or older
* Specialties involved: Nephrology, rheumatology, cardiology, endocrinology, pulmonology
* Listed for future appointments in two or more outpatient clinics
* Days between appointments less than 43

Exclusion Criteria

* Patients only undergoing patient education
* Appointments in relation to science or diagnosing
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Central Jutland Regional Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Peter Vedsted

Role: STUDY_DIRECTOR

Diagnostic Center, University Research Clinic for Innovative Patient Pathways

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Research Clinic for Innovative Patient Pathways, Diagnostic Centre, Silkeborg Regional Hospital

Silkeborg, Central Jutland, Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

634802

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.